Cell line name | CCRF-CEM R30dm |
---|---|
Synonyms | R30dm-CCRF-CEM; R30dm |
Accession | CVCL_V325 |
Resource Identification Initiative | To cite this cell line use: CCRF-CEM R30dm (RRID:CVCL_V325) |
Comments | Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX). Derived from sampling site: Peripheral blood. |
Sequence variations | Heterozygous for FLT3 p.Ala627Thr (c.1879G>A) (from parent cell line).Heterozygous for KRAS p.Gly12Asp (c.35G>A) (from parent cell line).Heterozygous for TP53 p.Arg175His (c.524G>A) and p.Arg248Gln (c.743G>A) (from parent cell line). |
Disease | Childhood T acute lymphoblastic leukemia (NCIt: C7953) |
Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|
Hierarchy | Parent: CVCL_V323 (CCRF-CEM R30/6) |
Sex of cell | Female |
Age at sampling | 3Y11M |
Category | Cancer cell line |
Publications | PubMed=2007575 |
Cross-references | |
Chemistry resources | ChEMBL-Cells; CHEMBL3307546
ChEMBL-Targets; CHEMBL614143 |
Other | Wikidata; Q54809023 |